Skip to content

Nitrates and IL-8 in Barrett's Esophagus

The Association Between Nitrates, Nitrosylated Proteins, and Interleukin-8 in Barrett's Esophagus and Esophageal Adenocarcinoma

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04642690
Enrollment
9
Registered
2020-11-24
Start date
2020-09-24
Completion date
2022-12-09
Last updated
2022-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett Esophagus, Esophageal Adenocarcinoma

Brief summary

The purpose of this study is to determine if nitrates and IL-8 (which are found in food and throughout the body regulating stomach acidity) play a role in Barrett's Esophagus and/or Esophageal Adenocarcinoma severity and if screening for these biomarkers can help predict patients that are more at risk for developing worsening disease.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Patients undergoing a clinicallly-indicated Esophagogastroduoedoscopy (EGD).

Exclusion criteria

* Comorbid inflammatory medical condition. * Use of antiinflammatory (aspirin and NSAIDs) or immunosuppressants over the past 1 week. * Use of nitrate containing medication in the past 1 week. * Consumption of nitrate rich foods in preceding 24 hours. * Known allergy to meat or nitrates

Design outcomes

Primary

MeasureTime frameDescription
Nitrate LevelsBaselineNitrate levels in serum, saliva and tissue in patients with normal squamous epithelium, erosive esophagitis, non-dysplastic BE (NDBE), and BE with high-grade dysplasia (HGD) or EAC
Serum and Tissue BiomarkersBaselineLevels of IL-8 in patients diagnosed BE dysplasia and EAC

Secondary

MeasureTime frameDescription
Biomarkers and disease progressionBaselineLevel of IL-8 in serum and tissue in patients with NDBE that progressed to BE

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026